Companies / Tandem Diabetes Care Inc
Tandem Diabetes Care Inc
Financials · FY2025
Ownership
69.6M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.56% | 392,799 |
| 10%+ / strategic | 4.15% | 2,889,691 |
| Institutions | 106.24% | 73,923,908 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 10
View all →| Insider | % of shares | Shares |
|---|---|---|
Sheridan John FCEOPRESIDENT & CEO · Director | 0.22% | 152,443 |
Morrison SusanEVP & Chief Admin. Officer | 0.06% | 42,635 |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER | 0.06% | 39,411 |
Novara Mark DavidEVP & CHIEF COMMERCIAL OFFICER | 0.05% | 37,656 |
Carpenter RickChief Technology Officer | 0.04% | 25,274 |
Twomey Christopher JDirector | 0.04% | 24,434 |
Kyrillos Jean-ClaudeEVP & Chief Operating Officer | 0.03% | 24,062 |
Hansen Shannon MarieEVP & Chief Legal Officer | 0.03% | 23,276 |
Robertson Rebecca BDirector | 0.03% | 22,542 |
Gasser Elizabeth AnneEVP, Chief Strategy Officer | <0.01% | 1,066 |
Institutional holders 274
View all →| Holder | Value | % of shares |
|---|---|---|
| $174.79M | 16.65% | |
| $161.36M | 10.55% | |
| $109.90M | 7.19% | |
| $63.52M | 4.15% | |
| $45.91M | 3.00% | |
| $45.73M | 2.99% | |
| $45.67M | 2.99% | |
| $44.43M | 2.91% | |
| $43.03M | 4.10% | |
| $37.00M | 2.42% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Trim | — | $-19.93M | -1.0M -83.28% | 208,713 0.30% of shares | medium |
| Q2 2024 as of | Barclays PLC 13F manager | Add | — | $14.34M | +356K +714.73% | 405,712 0.58% of shares | medium |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | — | $12.70M | +663K +55.15% | 1,864,194 2.68% of shares | medium |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Add | — | $10.87M | +567K +64.75% | 1,442,472 2.07% of shares | medium |
| Q1 2026 as of | Voya Investment Management LLC 13F manager | Add | — | $9.29M | +485K +151.66% | 804,137 1.16% of shares | medium |
| Q4 2024 as of | Barclays PLC 13F manager | Add | — | $8.86M | +246K +106.42% | 476,974 0.69% of shares | medium |
| Q3 2025 as of | Barclays PLC 13F manager | Add | — | $7.56M | +623K +109.87% | 1,190,127 1.71% of shares | medium |
| Q3 2024 as of | Barclays PLC 13F manager | Trim | — | $-7.41M | -175K -43.05% | 231,065 0.33% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| ArrowMark Colorado Holdings, LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| TNDM | — | 875372203 |